WEGOVY 2.4 mg, FlexTouch solution injectable en stylo prérempli pen, 3 ml + 4 needles
Brand page: Wegovy (semaglutide) — all forms and strengths in France
Active ingredients: Semaglutide
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionpen, 3 ml + 4 needlessous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- WEGOVY 2,4 mg, FlexTouch solution injectable en stylo prérempli
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 cartouche en verre de 3 mL dans stylo prérempli + 4 aiguilles
- Marketing authorisation holder
- NOVO NORDISK (DANEMARK)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 25 Sept 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61207647CIP73025866CIP133400930258668Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SÉMAGLUTIDEsolution | 2,4 mg · une dose dans 0,75 mL de solution i | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.